ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #708Top JournalHybrid

European Urology Oncology

Identifier (ISSN):2588-9311(Print)
•
Publisher:ELSEVIER
Clarivate IF (2026)
8.5↓ -0.8
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2022–2026)

Clarivate IF trend for European Urology Oncology

WoS Q1
5710128.2120228.220238.320249.320258.52026
Annual Impact Factor Metric
Current (2026):8.5
Scopus SJR & RankScopus Q1
3.01
#708

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
63

63 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate3.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
103articles/year
42.07% Gold OA•81.33% Original Research

Aims & Scope

European Urology Oncology (ISSN: 2588-9311) is a peer-reviewed international scholarly journal in the field of Multiple, published by ELSEVIER in England. The periodical holds a Journal Impact Factor (JIF) of 8.50, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 3.010 (Q1), an H-index of 63.

Topics Covered (Recognized by AI)
Medicine99.7%Biology86.8%Internal medicine86.8%Genetics84.6%Cancer78.5%Pathology62.3%Oncology54.7%Surgery50.9%Prostate cancer47.3%Radiology38.5%Mathematics36.8%Prostate36.6%Statistics34.7%Urology29.4%Chemistry25.5%Biochemistry23.7%Physics22.6%Bladder cancer20.9%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q1
Rank40/333
IndexSCIE
JCRSCIE2026

UROLOGY & NEPHROLOGY

Q1
Rank8/134
IndexSCIE
JCISCIE2026

ONCOLOGY

Q1
Rank23/333
IndexSCIE
JCISCIE2026

UROLOGY & NEPHROLOGY

Q1
Rank9/134
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

9 year
2026Latest
IF8.5
Articles / Year178
Total Citations121
2025
IF9.3
Articles / Year226
Total Citations790
2024
IF8.3
Articles / Year211
Total Citations2,193
2023
IF8.2
Articles / Year197
Total Citations3,247
2022
IF8.208
Articles / Year97
Total Citations2,521

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #708Scopus Q1SCImago Profile
Scopus Coverage:2018-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
3.01

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
5.89

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,028 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,584
3-Year Documents415
Citable Documents311

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)2

Citations in government and international policy documents

Female Author Rate31.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1
OncologyQ1
Radiology, Nuclear Medicine and ImagingQ1
SurgeryQ1
UrologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
2区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

European Urology Oncology (ISSN: 2588-9311) is a peer-reviewed international scholarly journal in the field of Multiple, published by ELSEVIER in England. The periodical holds a Journal Impact Factor (JIF) of 8.50, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 3.010 (Q1), an H-index of 63.

The journal enforces rigorous peer evaluation with an annual output of approximately 103 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,028 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
ELSEVIER
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusPubMed
Editorial Address
RADARWEG 29, AMSTERDAM, NETHERLANDS, 1043 NX

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 94bff83c-a171-4f9a-9b2d-659174b84d8e
Database Updated: 2026-10-16